References
Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in De Novo Stage IV breast cancer: results of a randomized clinical trial (EA2108). J Clin Oncol Official J Am Soc Clin Oncol. JCO2102006 (2022). https://doi.org/10.1200/JCO.21.02006
Khan SA. Does resection of an intact breast primary improve survival in metastatic breast cancer? Oncology (Williston Park). 2007;21(8):924–31; Discussion 931-2, 934, 942, passim.
Menta A, Fouad TM, Lucci A, et al. Inflammatory breast cancer: What to know about this unique, aggressive breast cancer. Surg Clin North Am. 2018;98(4):787–800. https://doi.org/10.1016/j.suc.2018.03.009.
Chen JC, Li Y, Fisher JL, et al. Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11975-6.
Akay CL, Ueno NT, Chisholm GB, et al. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014;120(9):1319–28. https://doi.org/10.1002/cncr.28550.
Funding
Samilia Obeng-Gyasi is funded by the Paul Calabresi Career Development Award (K12 CA133250)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, J.C., Bazan, J.G. & Obeng-Gyasi, S. ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol 29, 6689–6690 (2022). https://doi.org/10.1245/s10434-022-12016-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12016-y